These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 11413326
1. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65). Holtappels R, Podlech J, Grzimek NK, Thomas D, Pahl-Seibert MF, Reddehase MJ. J Virol; 2001 Jul; 75(14):6584-600. PubMed ID: 11413326 [Abstract] [Full Text] [Related]
2. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. Pahl-Seibert MF, Juelch M, Podlech J, Thomas D, Deegen P, Reddehase MJ, Holtappels R. J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154 [Abstract] [Full Text] [Related]
3. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ. J Immunother; 2006 May; 29(4):436-43; discussion 365-6. PubMed ID: 16799339 [Abstract] [Full Text] [Related]
4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ. Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493 [Abstract] [Full Text] [Related]
11. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. Jacobson MA, Sinclair E, Bredt B, Agrillo L, Black D, Epling CL, Carvidi A, Ho T, Bains R, Adler SP. J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547 [Abstract] [Full Text] [Related]
12. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice. Reiser M, Wieland A, Plachter B, Mertens T, Greiner J, Schirmbeck R. J Immunol; 2011 Sep 01; 187(5):2172-80. PubMed ID: 21810614 [Abstract] [Full Text] [Related]
13. Identification of T cell epitopes by the use of rapidly generated mRNA fragments. Britten CM, Meyer RG, Graf C, Huber C, Wölfel T. J Immunol Methods; 2005 Apr 01; 299(1-2):165-75. PubMed ID: 15914199 [Abstract] [Full Text] [Related]
14. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. Wang Z, La Rosa C, Lacey SF, Maas R, Mekhoubad S, Britt WJ, Diamond DJ. J Clin Virol; 2006 Mar 01; 35(3):324-31. PubMed ID: 16388983 [Abstract] [Full Text] [Related]
15. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ. J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550 [Abstract] [Full Text] [Related]
16. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM, Pruss A, Gratama JW, Volkmer-Engert R, Ewert R, Reinke P, Volk HD, Picker LJ. J Infect Dis; 2002 Jun 15; 185(12):1709-16. PubMed ID: 12085315 [Abstract] [Full Text] [Related]
17. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. Lim JB, Provenzano M, Kwon OH, Bettinotti M, Caruccio L, Nagorsen D, Stroncek D. Exp Hematol; 2006 Mar 15; 34(3):296-307. PubMed ID: 16543064 [Abstract] [Full Text] [Related]
18. Protection against murine cytomegalovirus retinitis by adoptive transfer of virus-specific CD8+ T cells. Bigger JE, Tanigawa M, Thomas CA, Atherton SS. Invest Ophthalmol Vis Sci; 1999 Oct 15; 40(11):2608-13. PubMed ID: 10509656 [Abstract] [Full Text] [Related]
19. CMV-specific TCR-transgenic T cells for immunotherapy. Schub A, Schuster IG, Hammerschmidt W, Moosmann A. J Immunol; 2009 Nov 15; 183(10):6819-30. PubMed ID: 19864595 [Abstract] [Full Text] [Related]
20. Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines. Meij P, Jedema I, Zandvliet ML, van der Heiden PL, van de Meent M, van Egmond HM, van Liempt E, Hoogstraten C, Kruithof S, Veld S, Marijt EW, von dem Borne PA, Lankester AC, Halkes CJ, Falkenburg JH. J Immunother; 2012 Oct 15; 35(8):621-8. PubMed ID: 22996368 [Abstract] [Full Text] [Related] Page: [Next] [New Search]